Shruti Gupta Profile picture
Mom, Wife, Onco-nephrologist. Founder and Co-president of American Society of Onco-Nephrology. Co-PI of STOP-COVID. Exercise and wine enthusiast
Dec 8, 2021 10 tweets 6 min read
Do cyclin-dependent kinase (CDK) 4/6 inhibitors cause acute kidney injury (AKI)? #onconephrology #Thread

A little #tweetorial about CDK 4/6 inhibitor-associated AKI: what we know already, and what we found
kireports.org/article/S2468-… 3 CDK 4/6 inhibitors (palbociclib, ribociclib, and abemaciclib)have been approved for HER2-negative metastatic breast cancers. CDK 4/6 inhibitors help overcome resistance to endocrine therapies by preventing cell-cycle progression and cancer growth (frontiersin.org/articles/10.33…).
Oct 8, 2021 11 tweets 7 min read
*NEW ARTICLE*
What does a nephrologist need to know about immune checkpoint inhibitor-associated AKI (ICPi-AKI)?@DavidLeaf9 #Thread
my first #tweetorial with help from @kdjhaveri
jitc.bmj.com/content/9/10/e… (1/11) Why does it matter? ICPi-AKI can lead to:
*Discontinuation of ICPi therapy
*Irreversible loss of kidney function
*Prolonged courses of immunosuppression (2/11)